norovirus and semaglutide Transmission ACG 2025 Annual Meeting

Retatrutide is currently in Phase 3 clinical trials, and while it is not FDA approved yet, the results have been very encouraging so far

Annu Rev Pharmacol Toxicol

Let us figure it out together right away

After a brief training session in our office, patients can confidently administer their injections at home

Recent FDA approvals have expanded the indication for semaglutide to include the reduction of major adverse cardiovascular events (MACE), such as heart attack, stroke, and cardiovascular death, in adults with established cardiovascular disease and obesity

If these become chronic problems, then, of course, they can be more damaging to the teeth, throat and esophagus, Garcia-Web noted